Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
Following the launch of hearing aid Ven in India, hearing aid manufacturer Audientes can fill in the revenues box in its accounting report for the very first time in its history.
The world’s biggest hearing aid manufacturer is expecting to increase sales by 17–21% in 2022/2023, which is a testament to a strong hearing aid market going forward, says an analyst.
Demand for hearing solutions is on the rise, supporting a market upswing, says the world’s biggest hearing aid manufacturer, which has just handed in its sales figures for the financial year 2021/2022.
US-based hearing firm Eargo, which has just settled a USD 34.4m case in the US, is now being threatened with delisting on the Nasdaq Stock Market in New York due to three consecutive missing financial reports.
Walther Thygesen has chosen to step down from hearing firm Sonion’s board of directors, and Dutch national Piet Coelewij has assumed the role.
Sonova remains the biggest supplier of hearing aids to American veterans, while the Danish hearing aid manufacturers inch forward on the public sales channel in April.
There’s no product category that allows GN Hearing to sell its hybrid hearing aid, Jabra Enhance Plus, on public sales channel Veterans Affairs – but GN Hearing is currently making its case to the institution.
A stringent focus on prices and costs has helped WS Audiology book a revenue growth of 20% despite global supply issues and increasing inflation, CEO Eric Bernard tells MedWatch.
The hearing aid manufacturer plans to invest around DKK 150m (USD 21.4m) on streamlining its supply chain in 2022. So far, the first DKK 29m (USD 4.1m) has gone to employee dismissals, GN Hearing CEO Gitte Aabo tells MedWatch.
US-based Bose was first to achieve a US approval for a direct-to-consumer hearing aid. Now, as they’re withdrawing from the market, there’ll be one less competitor to worry about, says GN Hearing CEO Gitte Aabo.
WS Audiology has released its figures for the second quarter of financial year 2021/2022, booking a revenue of EUR 581m. (Updated)
GN Hearing ended the first quarter of 2022 with an organic growth of 2%, though shipping costs led to a slightly disappointing operating result for the firm. (Updated)
If Bose believed it could achieve great success on the hearing aid market, the firm wouldn’t be dropping its business making said devices, says Sydbank analyst Søren Løntoft Hansen.
The hearing aid manufacturer recently publicized its 2022 Q1 report, and a Jyske Bank analyst now expects that Demant’s growth momentum will carry through the second quarter.
Following an independent analysis, audio firm Bose has decided to exit the hearing aid market, despite already having a direct-to-consumer, self-fitting hearing aid cleared by the FDA.
Italian hearing aid retailer Amplifon has just released its first quarterly report for 2022, spotlighting a topline result that surpasses analysts’ estimates by a hair.
When the geopolitical climate heats up, uncertainty grows, including on the hearing aid market. To reassure Demant’s investors, CEO Søren Nielsen has decided to start releasing quarterly reports, starting today.
The hearing aid manufacturer has already written off its activities in Russia, which is why the ongoing conflict won’t end up affecting the company more than the DKK 100m (USD 14m) negative impact it has already accounted for.
Tuesday’s quarterly report from Demant contains both some good and some bad elements, leaving readers with an overall neutral impression, according to a senior analyst at Sydbank.
Demant has started to publicize quarterly financial results as of today, when it revealed it is maintaining its 2022 guidance despite predicting sanctions on Russia will negatively impact its operating result. (Updated)
France’s healthcare reform makes for a difficult basis of comparison in the upcoming quarterly report from hearing aid manufacturer Demant, according to Jyske Bank.
Hearing firm Eargo pays USD 34.4m in a settlement, effectively ending the DOJ’s investigation into the firm’s reimbursement claims. Eargo admits no wrongdoing.
In the first quarter of 2022, the US hearing aid market has experienced tailwinds, lifting sales by 7.8 percent. This reflects that there is still demand left from when patients were unable to acquire devices during the pandemic, says an analyst writing for an industry media.
Hearing firm Estron, which has been without a permanent chief executive since January, has now appointed Peter Lyhne Uhrenholt to the helm.
Clinical Trial Manager 
Account Manager 
Director of Toxicology 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
IRT Manager, Clinical Drug Supply 
Director for innovative pre-clinical testing unit 
(Senior) Drug Substance Specialist 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Cell Culture Scientist/Senior Scientist 
2 Sales Representatives and Product Specialists 
Senior Chemical Safety Advisor Senior QA Specialist 
Key Account Manager, Europe and Asia Quality System Manager 
Production Director 
Senior IT Network Engineer Biostatistician Consultant Manager 
Client Talent Acquisition Specialist 
Industrial Designer- Design Engineer SAP System Specialist (Product Supply) – Business Application Services 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Senior Project Manager (GMP - Life Science) 
Project Manager & Scrum Master Innovation Project Manager, Display Unit 
